Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antifolate
    (3)
Filter
Search Result
Results for "

mirvetuximab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
Mirvetuximab
M9346A
T767661453084-36-0
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
  • Inquiry Price
Size
QTY
Mirvetuximab soravtansine
TAK-853, IMGN-853, IMGN853
T778251453084-37-1
Mirvetuximab soravtansine (IMGN853) is an antibody-drug coupling (ADC) targeting folate receptor alpha (FRα), which inhibits cell growth and enhances the antiproliferative effects of DNA damage, and may be useful in the study of drug-resistant ovarian cancer.
  • Inquiry Price
7-10 days
Size
QTY
Mirvetuximab MMAE
T9901A-218
Mirvetuximab-MMAE (CHB296), an Anti-FOLR1 Reference Antibody, is produced in CHO cells. This antibody features a huIgG1 heavy chain and a hukappa light chain, with a predicted molecular weight (MW) of 145.96 kDa.
  • Inquiry Price
Size
QTY
Mirvetuximab-DM4
M9346A-DM4
T9901A-480
Mirvetuximab-DM4 (M9346A-DM4) is a compound targeting FOLR1 with potential anti-cancer activity. It can be used to synthesize Mirvetuximab soravtansine and study ovarian cancer.
    Inquiry